- Home
- EPAM vs TFX Comparison
EPAM vs TFX Comparison
Compare EPAM & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EPAM | TFX |
|---|---|---|
| Founded | 1993 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 2011 | 1994 |
Fundamental Metrics
Financial Performance| Metric | EPAM | TFX |
|---|---|---|
| Price | $113.67 | $125.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | $122.82 | ★ $154.73 |
| AVG Volume (30 Days) | ★ 907.5K | 779.5K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.09% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.49 | 2.08 |
| Revenue | $1,450,448,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $3.66 | $13.82 |
| Revenue Next Year | $3.57 | $4.32 |
| P/E Ratio | ★ $32.62 | $59.71 |
| Revenue Growth | ★ 25.02 | N/A |
| 52 Week Low | $73.06 | $100.18 |
| 52 Week High | $222.53 | $145.00 |
Technical Indicators
Market Signals| Indicator | EPAM | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 54.48 | 39.31 |
| Support Level | $111.24 | $119.23 |
| Resistance Level | $121.53 | $128.06 |
| Average True Range (ATR) | 4.39 | 3.37 |
| MACD | -0.41 | 0.23 |
| Stochastic Oscillator | 54.24 | 57.03 |
Price Performance
Historical ComparisonAbout EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm with a focus on platform engineering, software development, and consulting services. The company used to host large engineer bases in Ukraine, Belarus, and Russia, but it now delivers from various locations across different continents. EPAM's largest market is North America, which represents approximately 60% of revenue.
About TFX Teleflex Incorporated
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.